Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Jerusalem, Israel
Countries of investment
  • Israel
Investment stages
  • Pre-Seed
  • Seed
Industries
    About
    Hadasit Bio Holdings serves as a strategic investment platform dedicated to advancing Israeli biotechnology companies that leverage intellectual property developed at Hadassah University Hospital. By providing robust financial backing and comprehensive support, Hadasit Bio Holdings facilitates the progression of these innovative ventures towards Phase II clinical trials. The company is committed to fostering cutting-edge research and development, thereby driving breakthroughs in the biotechnology sector and contributing to the global healthcare landscape. Through its unique position at the intersection of academia and industry, Hadasit Bio Holdings plays a pivotal role in bringing transformative medical solutions to market.
    Min check size
    $250K
    Max check size
    $5M
    Fund size
    NPS

    Investment Thesis

    Hadasit BioHoldings’ investment thesis revolves around investing in and developing groundbreaking life sciences and biotechnology innovations. The firm seeks to identify and support biotech startups with promising technologies and strong scientific foundations. Hadasit BioHoldings emphasizes collaboration with research institutions and leveraging its expertise to accelerate the commercialization of novel medical technologies.
    Lead investor
    Co Invest
    Number of exits
    Preferred contact method

    Hadasit BioHoldings Contacts Information

    Primary contact

    Fund number
    Vintage Year
    Net Internal Rate of Return
    Investment Multiple
    Capital Allocation
    Management Fee
    Carried Interest
    AUM
    Follow-on Investments
    Graduation Rate
    Write-Off Ratio
    Last profile update timestamp